insights_auto
Why is ARX up 8.16%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.53
arrow_upward
+8.16%(+0.040) 1D
Nov 6, 4:10:29 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.53
Low
A$0.46
Mkt. cap
183.33M
Avg. vol.
284.14K
Volume
553.67K
P/E ratio
51.36
52-wk high
A$0.80
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.53
Low
A$0.46
Mkt. cap
183.33M
Avg. vol.
284.14K
Volume
553.67K
P/E ratio
51.36
52-wk high
A$0.80
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Trefis
·
52 minutes ago
8 S&P 500 Stocks Just Made New 52-Week Highs
The Daily News | Texas' Oldest Newspaper
·
1 hour ago
Nasdaq rebounds but posts fourth straight weekly decline
BigGo Finance
·
8 hours ago
Dow Falls 237 Points as Strong Jobs Report Bolsters December Rate Hike Expectations; Nasdaq Rebounds
www.tmgm.com
·
9 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd